US43358Y2028 - Common Stock
HISTOGEN INC
NASDAQ:HSTO (10/4/2023, 7:13:37 PM)
After market: 0.6531 0 (-0.74%)0.658
+0.15 (+29.27%)
Histogen, Inc. engages in the development of potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function. The company is headquartered in San Diego, California and currently employs 7 full-time employees. The company went IPO on 2013-07-25. The firm is focused on developing clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body’s natural process to restore immune function. Its product candidates include emricasan, CTS-2090 and CTS-2096. The company develops emricasan for acute bacterial skin and skin structure infections (ABSSSI) as well evaluating its use for other infectious diseases. Its pipeline also includes novel preclinical product candidates including CTS-2090 and CTS-2096, which are selective small molecule inhibitors of caspase-1 designed for the treatment of certain inflammatory diseases. Emricasan is an orally available pan-caspase inhibitor designed to reduce the activities of human caspases, which are enzymes that mediate inflammation and apoptosis. CTS-2090 and CTS-2096 are selective caspase-1 inhibitors targeting inflammasome activation and to treat a variety of inflammation mediated diseases.
HISTOGEN INC
10655 Sorrento Valley Road, Suite 200
San Diego CALIFORNIA 92121
P: 18585263100.0
CEO: Richard W. Pascoe
Employees: 7
Website: https://histogen.com/
Histogen has filed for voluntary Chapt. 11 protection to maximize share offering...
Meeting Adjourned for a Final Time to January 4, 2024 at 8:00 a.m. PTPotential Estimated Cash Distribution to Shareholders of $0.30 to $0.41 if Dissolution...
Meeting Adjourned to December 14, 2023 at 8:00 a.m. PT
Meeting Adjourned to December 14, 2023 at 8:00 a.m. PT...
Here you can normally see the latest stock twits on HSTO, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: